Shingles News
-
Shingles Vaccine Bonus: Reduced Risk of Stroke?
Overall stroke risk dropped 20% among patients under age 80 who got the shingles vaccine. In patients 80 and older, risk was cut by about 10%, said researchers.
-
New Shingles Vaccine: What You Need To Know
The new vaccine is more than 90% effective at preventing shingles and a painful complication called postherpetic neuralgia (PHN) in all age groups.
-
Chickenpox Vaccine Shields Against Shingles Too
Kids who were vaccinated against chickenpox had a 78% lower risk of developing shingles, the researchers said.
-
More Shingles Vaccine On the Way, Maker Says
More doses of Shingrix, the shingles vaccine that has been in very short supply, are on the way to U.S. pharmacies, says drugmaker GlaxoSmithKline. However, demand may still outpace supply.
-
Shingles Vaccine Shortage Has Seniors Scrambling
For months, demand for Shingrix, the shingles vaccine approved by the FDA in October 2017, has outpaced supply, frustrating patients and providers alike.
-
Shingles on the Rise Among Younger People
Over the last six decades, there has been a steady uptick in the number of shingles cases in the United States -- even among younger adults. What's behind it? Researchers have a few theories.
-
Shortages Arise For New Shingles Vaccine
Supplies of a new and more effective shingles vaccine are running low in the United States.
-
FDA Approves New Shingles Vaccine
New vaccine, said to be more effective, is second approved for U.S. market.
-
Is Shingles Tied to Heart, Stroke Risk?
More research is needed, but doctors should warn patients, researchers say
-
Experimental Shingles Vaccine Looks Effective
Found to protect about 90 percent of adults age 70 and up
-
Shingles Linked to Raised Heart Risks for Seniors
Chance of stroke, heart attack increased most in the first week after diagnosis of the painful rash
-
Shingles Vaccine Appears to Cut Odds of Long-Term Pain
Findings support immunization of older adults
-
Shingles Vaccine May Be OK for Autoimmune Patients
The live-virus shingles vaccine may be safe for people with autoimmune conditions and for those taking immunity-suppressing drugs.
-
Risk of Shingles Recurrence Is Low
A new study offers up some encouraging news for people who have recently experienced a painful bout of shingles.
-
FDA Approves Horizant for Post-Shingles Pain
The FDA has approved a drug currently used for restless leg syndrome to treat a common and painful complication of shingles, according to the medication's manufacturers.
-
Shingles Vaccine Deemed Safe in Large Study
The shingles vaccine is “generally safe and well tolerated,” according to a study of nearly 200,000 patients.
-
FDA: Shingles Vaccine OK at Age 50 and Up
The FDA today approved Merck's Zostavax shingles vaccine for 50-somethings. The vaccine was already approved for people age 60 and older.
-
Shingles Vaccine Cuts Disease Risk 55%
The herpes zoster vaccine, better known as the shingles vaccine and recommended for adults 60-plus, cuts the risk of getting the painful disease by 55%, new research finds.
-
New PHN Drug Cuts Lingering Shingles Pain
The FDA has approved Qutenza for post-herpetic neuralgia (PHN), lingering nerve pain after a shingles attack. The doctor-applied patches deliver synthetic capsaicin, the chemical that makes chili peppers hot.
-
Shingles Recurs More Often Than Thought
People with shingles are more likely to suffer a recurrence than previously thought, especially if their attack is accompanied by lasting pain, researchers report.
-
Shingles May Raise Risk of Stroke
Adults with shingles are at increased risk for stroke, especially if they have shingles that affects the eyes, a study shows.
-
Pump Away Shingles Pain?
A surgically implanted pump that delivers medication to the spinal fluid helps reduce the persistent pain that can linger in some patients after they recover from shingles, according to a new study.
-
Family History Ups Shingles Risk
A new study shows that people with shingles, or herpes zoster infection, are more than four times likely to have a first-degree relative with a history of the condition.
-
Age 60 or Older? Get Shingles Vaccine
The CDC recommends that people aged 60 and older get a single dose of the shingles vaccine Zostavax.
-
1 Million Shingles Patients in U.S.
There are 1.1 million shingles patients in the U.S., and almost all of them seek shingles treatment each year, new government statistics show.
Pagination